STAT1 and viral infectious disease: While the production of type I and type II interferons produced early during viral infection can largely inhibit lung ILC2 proliferation and function in a STAT1-dependent manner [11,12], ILC2 can serve vital tissue repair function following the resolution of influenza infection through the production of amphiregulin (AREG) in response to local IL-33 production [13].